Sponsor or institution

Clinical trials and research at NEOK Bio, Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Targeted cancer therapy using NEOK002 for select solid tumors

  This first-in-human study tests NEOK002, a bispecific antibody-drug conjugate, in people with locally advanced or metastatic solid tumors to see if it is safe and tolerable.

  Recruiting at 10 sites Phase 1 NEOK Bio, Inc. · Orlando, Florida and 9 other locations · NCT07612189

• NEOK001: a new B7-H3 and ROR1-targeting cancer treatment given by IV infusion

  This early-phase study tests NEOK001, a bispecific antibody-drug conjugate, in people with locally advanced or metastatic solid tumors to see if it is safe and how it behaves in the body.

  Recruiting at 9 sites Phase 1 NEOK Bio, Inc. · New York, New York and 8 other locations · NCT07612176

Quick answers

How many clinical trials run by NEOK Bio, Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →